Your browser doesn't support javascript.
loading
Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia.
Yang, Zhiping; Bedugnis, Alice; Levinson, Susan; Dinubile, Mark; Stossel, Thomas; Lu, Quan; Kobzik, Lester.
Afiliação
  • Yang Z; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Bedugnis A; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Levinson S; BioAegis Therapeutics, North Brunswick, New Jersey.
  • Dinubile M; BioAegis Therapeutics, North Brunswick, New Jersey.
  • Stossel T; BioAegis Therapeutics, North Brunswick, New Jersey.
  • Lu Q; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Kobzik L; Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
J Infect Dis ; 220(9): 1498-1502, 2019 09 26.
Article em En | MEDLINE | ID: mdl-31287867
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Pneumocócica / Gelsolina / Fatores Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Infect Dis Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Pneumocócica / Gelsolina / Fatores Imunológicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Infect Dis Ano de publicação: 2019 Tipo de documento: Article